Skip to main content
Equibles
ELTP $0.29 +0.31%
ELTP logo
ELTP · Elite Pharmaceuticals Inc /Nv/
Track ELTP — free

Use ELTP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.29 +0.00 (+0.31%) At close · Aug 28
Rebalance outlook locked
Market Cap
$312.37M
Shares
1.08B
All earnings calls

Earnings call · FY2024 Q2

Elite Pharmaceuticals Inc (ELTP) Q2 2024 Earnings Call

Concluded Nov 14, 2023
Nov 14, 2023 0 turns
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $14.16M +64.9% YoY
Diluted EPS $0.01
Gross margin 45.5% +1.0 pp YoY
Net income $14.93M +885.7% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 14, 2023 10-Q report Filed Nov 14, 2023

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Manufacturing$13.51M
Licensing$649,315
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)